Viriditoxin
Viriditoxin ((-)-Viriditoxin) is a mycotoxin. Viriditoxin promotes tubulin polymerization, and inhibits FtsZ polymerization and GTPase activity. Viriditoxin exhibits cytotoxicity against cancer cells, induces apoptosis, inhibits cell migration and colony formation, induces G2/M phase arrest, and triggers autophagic cell death. Viriditoxin activates caspase-3, cleaves PARP, promotes cytochrome c release, and induces ROS production. Viriditoxin possesses broad-spectrum antibacterial activity against Gram-positive pathogenic bacteria, fish pathogenic bacteria, and permeabilized Gram-negative bacteria. Viriditoxin can be used in research related to ovarian cancer, lung cancer, nasopharyngeal carcinoma, colon cancer, neuroblastoma, prostate cancer, leukemia, lymphoma, bacterial infections, and streptococcosis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1381782-08-6
- 分子式: C34H30O14
- 分子量:662.60
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
Caspase アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
体外実験
Viriditoxin (10-100 µM; 1 h) promotes the polymerization of purified porcine brain tubulin in vitro[1].
Viriditoxin (0-100 µM; 24 h) converts soluble tubulin into polymerized particulate fractions in SK-OV-3 cells in a concentration-dependent manner, enhances tubulin polymerization and stabilizes microtubules in SK-OV-3 cells, leading to the formation of dense pericytoplasmic microtubule structures and disorganized perinuclear microtubule bundles[1].
Viriditoxin (0.048-30 µM; 24 h) inhibits the viability of SK-OV-3 cells with an IC50 of 14.3 µM, and induces characteristic cytotoxic morphological changes[1].
Viriditoxin (0-40 µM; 24 h) induces concentration-dependent G2/M phase arrest, concentration-dependent apoptosis, and inhibits migration and colony formation in SK-OV-3 cells[1].
Viriditoxin (0.05-20 μM; 24-48 h) inhibits the proliferation of LNCaP, DU145 and PC3 cells, with the strongest inhibitory activity against LNCaP cells (48 h IC50 = 0.63 μM)[2].
Viriditoxin (0.1-1 μM; 48 h) induces G2/M phase arrest in LNCaP cells, increases the proportion of cells in the sub-G1 phase, and is accompanied by altered expression of key cell cycle regulatory proteins. It also mildly induces apoptosis, triggers autophagic cell death, and induces mitotic catastrophe[2].
Viriditoxin (0.0002-200 μg/mL; 15 min) potently inhibits the polymerization of fluorescein-labeled *E. coli* FtsZT65C protein, with a mean IC50 value of 8.2 μg/mL[3].
Viriditoxin (200 μg/mL; 120 min) inhibits the GTPase activity of wild-type and luciferase-labeled *Escherichia coli* FtsZ protein, with an average IC50 of 7.0 μg/mL[3].
Viriditoxin (12.5-100 μg/mL; 75 min) induces filament formation in permeabilized, SulA-deficient E. coli MB5431 cells, indicating that it inhibits bacterial cell division[3].
Viriditoxin (2-32 μg/mL; 20-24 h) exhibits broad-spectrum antibacterial activity against Gram-positive pathogens (including drug-resistant strains), inhibits permeabilized E. coli MB5431 at a concentration of 25 μg/mL, and shows no cytotoxicity against Candida albicans or HeLa cells at concentrations >64 μg/mL and >66.7 μg/mL, respectively[3].
Viriditoxin (0.01-100 μM; 5 min-72 h) potently induces cytotoxicity in human leukemia and lymphoma cell lines, with IC50 values ranging from 0.04 μM (72 h, Ramos) to 1.66 μM (24 h, K562), and even a short exposure of only 5 minutes causes irreversible cell death in Ramos cells[5].
Viriditoxin (0.01-30 μM; 8-24 h) potently induces caspase-dependent apoptosis in Ramos and Jurkat cells with a rapid kinetic process: it activates caspase-3, cleaves PARP, and increases the number of apoptotic nuclei in a dose-dependent manner at 3-5 h[5].
Viriditoxin (0.01-30 μM; 8-24 h) activates the mitochondrial apoptotic pathway independently of Bcl-2 overexpression and the presence of Bax/Bak, but its induction of apoptosis in leukemia/lymphoma cells requires the involvement of caspase-9[5].
Viriditoxin (0.01-100 μM; 5 min-24 h) impairs the structure and function of mitochondria in leukemia/lymphoma cells, triggering rapid collapse of membrane potential, cytochrome c release, OPA1 cleavage, mitochondrial fragmentation, and ROS production, with its cytotoxicity partially mediated by ROS[5].
Viriditoxin (0.01-10 μM; 15 min-24 h) impairs mitochondrial respiratory function in leukemia cells by inhibiting the activity of ETC complex I and reducing the expression of key ETC subunits, thereby leading to decreases in ATP levels and oxygen consumption[5].
Viriditoxin (0.16-0.21 mg/mL) potently inhibits the growth of Gram-positive fish pathogens Streptococcus iniae, Streptococcus parauberis, as well as the human pathogen Staphylococcus aureus, with MIC values ranging from 0.16 to 0.21 mg/mL, but shows no activity against the Gram-negative fish pathogen Vibrio ichthyoenteri strains[6].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:SK-OV-3 human ovarian cancer cells
-
Concentration:10, 25, 50 µM
-
Incubation Time:24 h
-
Result:Induced a concentration-dependent shift of soluble tubulin to the particulate (polymerized) fraction, similar to the microtubule-stabilizing effect of paclitaxel.
-
Cell Line:SK-OV-3 human ovarian cancer cells
-
Concentration:15 µM (24 h incubation); 100 µM (1 h and 4 h incubation)
-
Incubation Time:1 h, 4 h, 24 h
-
Result:Increased microtubule density and formed long, thick, disarrayed microtubule bundles surrounding the nucleus after treatment with 100 µM for 4 h.
Enhanced tubulin polymerization with highly dense microtubule linings close to the cell membrane after 24 h at 15 µM, distinct from the multipolar spindles induced by paclitaxel.
-
Cell Line:SK-OV-3 human ovarian cancer cells
-
Concentration:0.048, 0.24, 1.2, 6, 30 µM
-
Incubation Time:24 h
-
Result:Inhibited SK-OV-3 cell viability in a dose-dependent manner, with an IC50 value of 14.3 µM.
Induced morphological changes including cytoplasmic shrinkage, cellular flattening, and rugged cell peripheries with fragments.
-
Cell Line:SK-OV-3 human ovarian cancer cells
-
Concentration:5, 10, 20, 40 µM
-
Incubation Time:24 h
-
Result:Increased the population of SK-OV-3 cells in the G2/M phase in a concentration-dependent manner (from 17.6% at 5 µM to 27.2% at 40 µM).
Decreased the G0/G1 population (from 70.7% at 5 µM to 52.0% at 40 µM).
Increased the S phase population (from 7.6% at 5 µM to 12.0% at 40 µM).
-
Cell Line:SK-OV-3 human ovarian cancer cells
-
Concentration:5, 10, 20, 40 µM
-
Incubation Time:24 h
-
Result:Induced a concentration-dependent increase in early and late apoptotic cell death: at 40 µM, live cells decreased to 76.0%, early apoptosis increased to 10.9%, and late apoptosis increased to 11.0%.
-
Cell Line:SK-OV-3 human ovarian cancer cells
-
Concentration:2.5, 5, 10 µM
-
Incubation Time:24 h
-
Result:Inhibited SK-OV-3 cell migration in a concentration-dependent manner; at 10 µM, migration was significantly reduced relative to controls.
-
Cell Line:human prostate cancer LNCaP, DU145, and PC3 cell lines
-
Concentration:0.05, 0.1, 0.5, 1, 5, 10, 20 μM
-
Incubation Time:24 h; 48 h
-
Result:Inhibited the growth of all three prostate cancer cell lines in a concentration- and time-dependent manner.
Exhibited IC50 values of 14.84 μM for LNCaP cells, 18.47 μM for DU145 cells, and 18.72 μM for PC3 cells after 24 h treatment.
Showed decreased IC50 values of 0.63 μM for LNCaP cells, 5.36 μM for DU145 cells, and 7.60 μM for PC3 cells after 48 h treatment.
Induced morphological changes including cytoplasmic shrinkage and cellular flattening in LNCaP cells after 48 h.
-
Cell Line:human prostate cancer LNCaP cells
-
Concentration:0.1, 0.5, 1 μM
-
Incubation Time:48 h
-
Result:Significantly increased the percentage of LNCaP cells in the G2/M phase and decreased the percentage of cells in the S phase in a concentration-dependent manner.
Increased the proportion of cells in the sub-G1 phase, an indicator of apoptosis.
Decreased expression levels of cyclin A, cyclin B1, and Cdc2, while increasing expression of cyclin E, Cdk2, p27, p53, and p21 in a concentration-dependent manner.
-
Cell Line:human prostate cancer LNCaP cells
-
Concentration:0.1, 0.5, 1 μM
-
Incubation Time:48 h
-
Result:Caused only a slight concentration-dependent increase in apoptotic cell death, most noticeable at the highest viriditoxin concentration.
Revealed an increase in apoptotic nuclei with condensed or fragmented chromatin compared to untreated controls via DAPI staining.
Increased expression levels of cleaved PARP, Bax, cytochrome c, and cleaved caspase-3, while decreasing Bcl-2 expression in LNCaP cells at high concentrations.
-
Cell Line:human prostate cancer LNCaP cells
-
Concentration:0.1, 0.5, 1 μM
-
Incubation Time:48 h
-
Result:Significantly increased the level of LC3-II and increased expression of autophagy initiation proteins beclin-1, Atg5, and Atg7 in a concentration-dependent manner via western blot analysis.
Induced a concentration-dependent increase in red fluorescent acidic vesicular organelles, confirmed by flow cytometric analysis showing increased red fluorescence intensity.
化学情報
-
CAS 番号 1381782-08-6
-
分子量 662.60
-
分子式 C34H30O14
-
SMILES
O=C1OC(CC(=O)OC)CC2=CC3=C(C(O)=CC(OC)=C3C4=C(OC)C=C(O)C=5C(O)=C6C(=O)OC(CC(=O)OC)CC6=CC54)C(O)=C12
-
別名
(-)-Viriditoxin
-
Structure Classification
-
Initial Source
Aspergillus viridinutans
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Chemotaxis Gradient Chamber Assay 1
The chemotaxis gradient chamber assay is based on the principle of observing directional cell migration in response to a stable, linear or quasi-linear concentration gradient of a chemoattractant formed between two fluid reservoirs separated by a narrow observation chamber. Cells placed within the chamber respond to the gradient by polarized movement toward higher chemoattractant concentrations, allowing quantification of chemotactic behavior in real time under microscopy. The classic Zigmond chamber design enables simultaneous visualization of gradient formation and individual cell trajectories, making it suitable for studying leukocyte chemotaxis and other motile cell types in vitro.
-
Under-Agarose Cell Migration Assay
The under-agarose cell migration assay is a classical in vitro chemotaxis method designed to evaluate directed cell movement through a semi-solid agarose matrix toward soluble chemoattractant gradients, enabling visualization and quantification of leukocyte or motile cell migration in a confined 2D-like environment. In this system, cells and chemoattractants are placed in separate wells cut into an agarose gel, allowing diffusion-driven gradient formation that guides directional migration, which is typically assessed by measuring migration distance, cell morphology changes, and accumulation toward the chemoattractant source. This assay has been widely used to study neutrophil and leukocyte chemotaxis as a simple alternative to filter-based migration systems and allows direct microscopic observation of migrating cells under near-physiological confinement conditions.
-
Transwell/Boyden Chamber Migration Assay
The Transwell/Boyden chamber migration assay measures cell movement through a porous membrane separating an upper and lower chamber, usually after a chemoattractant gradient is established by placing cells in the upper chamber and chemoattractant-containing medium in the lower chamber. The readout is generated by quantifying cells that traverse the membrane and appear on the lower membrane surface or in the lower chamber, depending on whether the cell type is adherent or non-adherent. This assay reflects chemotactic or haptotactic migration rather than matrix invasion unless an extracellular-matrix barrier is added to the membrane.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
3D Collagen/Hydrogel Matrix Migration Assay
The 3D collagen/hydrogel matrix migration assay is based on embedding cells within or on top of a fibrillar collagen type I-rich three-dimensional matrix to model in vivo-like extracellular matrix (ECM) architecture, enabling analysis of cell migration through a physically and biochemically relevant scaffold. In contrast to 2D migration systems, cells in 3D matrices interact with fibrillar collagen networks, requiring coordinated adhesion remodeling and proteolytic or non-proteolytic deformation mechanisms to move through confined spaces, thereby providing a more physiologically relevant readout of invasive and migratory behavior in tissue-like environments. Cell movement in 3D collagen matrices is typically quantified by tracking single-cell trajectories, invasion depth, or matrix penetration over time, reflecting combined effects of cytoskeletal dynamics, cell-ECM adhesion turnover, and ECM remodeling. These systems are widely used to study tumor cell invasion and stromal cell motili
-
Soft Agar Colony Formation Assay
Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures.
-
Cell-Exclusion Zone Migration Assay
The Cell-Exclusion Zone (CEZ) migration assay is an in vitro 2D cell migration method in which a defined cell-free area is created using removable physical barriers such as silicone stoppers, allowing cells to be seeded around the barrier and subsequently migrate into the cleared zone after barrier removal. This approach enables quantification of collective cell migration by monitoring repopulation of the initially cell-free region over time using microscopy-based imaging. Compared with scratch-based wound healing assays, barrier-based exclusion methods are designed to avoid mechanical damage to the extracellular matrix and reduce injury-induced effects on boundary cells, thereby improving interpretability of migration behavior in vitro. The assay readout is typically the progressive reduction in the cell-free area or the number of cells invading the exclusion zone, reflecting coordinated cell motility relevant to physiological processes such as wound healing, epithelial repair, and ca
-
Chemotaxis Gradient Chamber Assay 2
Chemotaxis gradient chamber assays measure directional cell migration in response to a soluble chemical gradient by imaging cells as they move across a defined observation region; the readout is generated from time-lapse cell trajectories, displacement toward the gradient, forward migration index, trajectory plots, rose/polar plots, and statistical tests of non-random directionality. The Dunn chamber is a direct-viewing glass chamber in which cells migrate across a bridge between control and chemoattractant wells, allowing observation of cells in a linear concentration gradient; related direct-viewing formats include the Insall chamber, which supports defined unidirectional gradients and high numerical-aperture microscopy, and the μ-Slide Chemotaxis chamber, which supports long-term live-cell imaging and gradient characterization with fluorescent dye.
-
Scratch/Wound-Healing Migration Assay
The scratch/wound-healing migration assay measures collective migration of adherent cells into an experimentally created cell-free gap in a confluent monolayer. The readout is generated by imaging the gap immediately after scratching and at later time points, then quantifying reduction in wound area, wound width, or percentage closure as cells move into the denuded region. Gap closure reflects cell migration but may also include cell proliferation, so interpretation should distinguish migration-focused conditions from proliferation-driven closure when possible, such as by using short assay windows, serum-controlled conditions, cell counting, or proliferation controls reported in published protocols.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Neural Crest/Neuronal Cell Migration Explant Assay
Neural crest (NC) and neuronal cell migration explant assays are in vitro systems in which neural tube-derived tissues are cultured to allow premigratory or newly emigrated neural crest cells to undergo epithelial-to-mesenchymal transition (EMT), migrate away from the explant, and form a measurable radial outgrowth that reflects migratory capacity and environmental responsiveness. These assays typically quantify migration by measuring the expansion of cell outgrowth from neural tube or neural plate border explants over time, often comparing early and later timepoints to derive a migration index such as a radius ratio, which reflects net cell dispersal from the explant core. Neural tube explant cultures preserve key aspects of neural crest behavior, including EMT, migration, and early differentiation, making them suitable for assessing intrinsic migratory ability and extrinsic cue dependence. However, studies emphasize that migratory outgrowth from neural tube explants may include non-n
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Colony Formation (Clonogenic) Assay
The clonogenic (colony formation) assay measures the ability of a single cell to retain reproductive viability and form a macroscopic colony, typically defined as a cluster derived from one progenitor cell after a defined growth period. This assay is widely used to evaluate cell survival after exposure to ionizing radiation or cytotoxic treatments and is considered a standard method in radiation biology for generating dose-response relationships of reproductive cell death. Colony formation reflects long-term proliferative capacity rather than short-term metabolic activity, and survival is quantified by comparing treated versus untreated conditions based on colony number and derived survival fractions.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Protocol for Fluorescence In Situ Hybridization (FISH)
Fluorescence in situ hybridization detects specific DNA or RNA sequences inside fixed cells or tissue sections by hybridizing fluorescently labeled nucleic-acid probes to complementary target sequences, allowing the target’s copy number, chromosomal position, spatial distribution, or transcript abundance to be visualized microscopically. DNA-FISH detects genomic loci, chromosomal gains/losses, amplifications, deletions, and rearrangements, while RNA-FISH detects RNA molecules or transcript localization; in cancer cells, mouse tumors, neurons, organoids, macrophages, or drug-screening samples, the readout is fluorescent puncta, fusion/split signals, or localized RNA signal interpreted relative to validated controls.
純度とドキュメンテーション
参考文献
[1]. Su M, et al. Viriditoxin Stabilizes Microtubule Polymers in SK-OV-3 Cells and Exhibits Antimitotic and Antimetastatic Potential. Marine drugs. 2020 Aug 27;18(9):445. [Content Brief]
[2]. Kundu S, et al. Viriditoxin regulates apoptosis and autophagy via mitotic catastrophe and microtubule formation in human prostate cancer cells. International journal of oncology. 2014 Dec;45(6):2331-40. [Content Brief]
[3]. Wang J, et al. Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics. The Journal of biological chemistry. 2003 Nov 07;278(45):44424-8. [Content Brief]
[4]. Grove CI, et al. Second-Generation Synthesis of (-)-Viriditoxin. Synthesis. 2012;2012(3):362-371. [Content Brief]
[5]. Stuhldreier F, et al. The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism. Cell death & disease. 2022 Nov 08;13(11):938. [Content Brief]
[6]. Noh TH, et al. Antibacterial activities of viriditoxin congeners and synthetic analogues against fish pathogens. Bioorganic & medicinal chemistry letters. 2017 Nov 15;27(22):4970-4974. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- Viriditoxin
- 1381782-08-6
- (-)-Viriditoxin
- Microtubule/Tubulin
- Apoptosis
- Autophagy
- Caspase
- PARP
- Reactive Oxygen Species (ROS)
- Bacterial
- Escherichia coli
- leukemia cells
- FtsZ
- tubulin
- mitochondrial electron transport chain complex I
- SK-OV-3 human ovarian cancer cells
- Candida albicans
- Gram-positive bacteria
- lymphoma cells
- LNCaP human prostate cancer cells
- Inhibitor
- inhibitor
- inhibit